Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...
Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Rhythm Pharmaceuticals in ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $69.89, with a ...
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia a New registry study to focus on impact of fatigue in people with craniopharyngiomaBOSTON, March 18 ...
Weight loss gummies claim to burn fat, suppress hunger, and boost your metabolism to help with weight loss, but these ...
Liquidia Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat ...
At close: March 27 at 4:00:01 PM EDT ...